|August 01, 2008|
Functional Technologies Announces Change to Investor Relations Program
|VANCOUVER, BRITISH COLUMBIA --- August 1, 2008 --- Functional Technologies Corp. (TSXV: FEB) today announced the termination of its investor relations agreement with Ascenta Capital Partners Inc. effective August 28, 2008. |
"We would like to thank Ascenta for their professionalism and commitment to Functional Technologies during the tenure of our investor relations agreement," commented Howard Louie, CEO of Functional Technologies.
About Functional Technologies Corp.
Functional Technologies is a functional foods and biological health products company that develops and commercializes advanced yeast products, and other novel biological products, for the food and the health care industries. The Company is currently commercializing a platform yeast technology that substantially reduces the formation of ethyl carbamate (also known as urethane, which has been recently reclassified by the World Health Organization up to a Group 2A carcinogen - the same carcinogen class as lead, mercury, acrylamide and diesel exhaust), from wines and other fermented beverages and foods. Functional Technologies has licensed the exclusive worldwide rights to this technology from The University of British Columbia (UBC). The company is expanding the development of next generation products in this area, as well as evaluating new yeast based technologies with broad commercial market applications. In addition Functional Technologies, through its wholly-owned subsidiary Phyterra Bio Inc., is developing a platform of proprietary biological products, for animal health, utilizing proprietary science in the field of micro-algae.
For further information, contact:
Functional Technologies Corp.
Hogan Mullally, Investor Relations
Toll Free: 888.442.4106
You can view the Next News Releases item: Tue Sep 16, 2008, Functional Technologies Announces The Granting Of Australian Patent
You can view the Previous News Releases item: Thu Jul 24, 2008, Functional Technologies Acquires Product Development and Laboratory Facility
You can return to the main News Releases page, or press the Back button on your browser.